Ca2+ is a flexible signaling molecule that regulates various physiological functions (Genovese et al. 6; Jacobson et al. 213; Clapham 1047; Courjaret et al. 2; Gautier 2; Alvarez et al. 204; Duchen 57). Separate signaling pathways permit tight Ca2+ control, which, when combined with the elastic machinery’s unique Ca2+ receptivity, allows for even more perfect VSM contractility (Ghosh et al. 50; Feiteiro et al. 580). Calcium modulates cytoskeleton proteins including actomyosin and tubulin, and at high doses, it can even trigger microtubule depolymerization (Umemoto et al. 2098; Nicholls 1373; Giorgi et al. 37). Ca2+ is involved in several critical biochemical elements that influence the survival and death of cells, particularly resistance and regulated pathways of cell death, including cell autophagy, necrosis, and cell cycle (Giorgi 258; Pinton et al. 6407; Orrenius et al. 552).
In several tissues, mitochondria may function as a regional Ca2+ buffer, modulating the transient Ca2+ concentration in the cell micro-domain (Duchen 57). This process controls functions that rely on local cytoplasmic Ca2+ concentrations such as Ca2+ flow across the -gated channels (Duchen 57). Chondrosomes utilize calcium ions as well as ions from the surrounding protoplasm (Irannejad and Zastrow 109). If the presence of calcium in the chondrosome rises excessively, the chondrosomal membrane becomes more porous, increasing absorption in a positive feedback mechanism (Irannejad and Zastrow 109). Increased chondrosomal porosity can result in a necrotic overload mechanism, which prevents ATP generation and, if left uncontrolled, can culminate in the complete collapse of the chondrosome (Irannejad and Zastrow 109).
When the ligand attaches to the GPCR, the q component of G-protein is triggered, which then triggers phospholipase C (PLC), a cell membrane protein (Dhyani et al. 3). PLC converts phosphatidylinositol 4,5-bisphosphate (PIP2), a phosphatide component of the plasma membrane, to IP3 and diacylglycerol once active (DAG) (Dhyani et al. 3). Because IP3 is permeable in the protoplasm, it disperses throughout the cell and attaches to the IP3-receptor (IP3R) on the outside of the ER or SR, causing Ca2+ to be transported from the ER or SR to the protoplasm (Dhyani et al. 3).
Cells use several elements of the Ca2+ signaling toolbox, such as Ca2+ entry and Ca2+ ejection mechanisms, to appropriately regulate intracellular Ca2+ impulses in a timing and space-dependent approach (Schwaller 1; McMahon et al. 244). Ca2+ absorbers, a group of cytosolic Ca2+-binding polypeptides, play the role of oscillators, mainly close to the end Ca2+ impulses (Schwaller 1; Nicholls 1374; Galluzzi et al. 1200; Mikoshiba 1426). An apoptotic signal, like the release of neurotrophins or exposure to chemicals, induces a pro-apoptotic constituent of the Bcl-2 protein family, like Bax, to permeabilize the outer mitochondrion in the intrinsic route (Franklin 1437). This permits cytochrome c to be redistributed from the chondrosomal intermembrane gap into the cytosol, where it activates caspase proteases, resulting in the death of cells (Franklin 1437).
Multiple elements of mitochondrial malfunction have been linked to various common diseases, making mitochondria a potential pharmaceutical target for the management of a broad spectrum of ailments (Javadov et al. 1177; Varghese et al. 3017). Mitochondria are significant actors in cancer growth because of their ability to provide required key components for anabolic physiology (Genovese et al. 9; Gautier et al. 2). Additionally, Genovese et al. insinuate the capacity of the mitochondria to develop ROS that has essential involvement in the induction of the death of cells communication by reducing cancer cell growth (9). Numerous mainstream medications have been modified to boost anticancer properties by binding mitochondria-targeting molecules (Genovese et al. 14; Fujisawa et al. 5). For example, drug resistance appears to be reduced by triphenylphosphonium enzyme doxorubicin (Genovese et al. 14). Furthermore, Genovese et al. (14) suggest that the chondrosome-targeted variant of glycyrrhetinic acid causes death in tumor cell lines via inducing membrane leakage shift.
Works Cited
Alvarez, Javier, et al. The Role of Ca2+ Signaling in Aging and Neurodegeneration: Insights from Caenorhabditis Elegans Models. Cells, 2020.
Clapham, David E. Calcium Signaling. Cell, 2007.
Courjaret, Raphaël, and Khaled Machaca. Mid-range Ca 2+ Signalling Mediated by Functional Coupling between Store-Operated Ca 2+ Entry and IP 3-Dependent Ca 2+ Release. Nature Communications, 2014.
Dhyani, Vaibhav, et al. GPCR Mediated Control of Calcium Dynamics: A Systems Perspective. Cellular Signalling, 2020.
Duchen, Michael R. Mitochondria and Calcium: From Cell Signalling to Cell Death. The Journal of Physiology, 2000.
Feiteiro, Joana, et al. “Inhibition of L-type calcium channels by Bisphenol A in rat aorta smooth muscle.” The Journal of Toxicological Sciences 43.10 (2018): 579-586.
Franklin, James L. Redox Regulation of the intrinsic pathway in Neuronal Apoptosis. Antioxidants & Redox Signaling, 2011.
Fujisawa, Koichi, et al. Modulation of Anticancer Drug Sensitivity through the Regulation of Mitochondrial Activity by Adenylate Kinase 4. Journal of Experimental & Clinical Cancer Research, 2016.
Galluzzi, Lorenzo, et al. Mitochondrial Control of Cellular Life, Stress, and Death. Circulation Research, 2012.
Gautier, Mathieu, et al. Ca2+ Channels in Cancer, 2019.
Genovese, Ilaria, et al. Mitochondria as the Decision Makers for Cancer Cell Fate: From Signaling Pathways to Therapeutic Strategies. Cell Calcium, 2020.
Ghosh, D., et al. Calcium Channels in Vascular Smooth Muscle. Advances in Pharmacology, 2017.
Giorgi, Carlotta, et al. Calcium Dynamics as a Machine for Decoding Signals. Trends in Cell Biology, 2018.
Giorgi, Carlotta, et al. Mitochondrial Ca2+ and Apoptosis. Cell Calcium, 2012.
Irannejad, Roshanak, and Mark von Zastrow. GPCR Signaling Along the Endocytic Pathway. Current opinion in cell biology, 2014.
Jacobson, Jake, and Michael R. Duchen. Interplay between Mitochondria and Cellular Calcium Signalling. Molecular and Cellular Biochemistry, 2004.
Javadov, Sabzali, Andrey V. Kozlov, and Amadou KS Camara. Mitochondria in Health and Diseases, 2020.
McMahon, Shane M., Che-Wei Chang, and Meyer B. Jackson. Multiple Cytosolic Calcium Buffers in Posterior Pituitary Nerve Terminals. Journal of General Physiology, 2016.
Mikoshiba, Katsuhiko. IP3 Receptor/Ca2+ Channel: From Discovery to New Signaling Concepts. Journal of Neurochemistry, 2007.
Nicholls, David G. Mitochondrial Function and Dysfunction in the Cell: Its Relevance to Aging and Aging-Related Disease. The International Journal of Biochemistry & Cell Biology, 2002.
Orrenius, Sten, Boris Zhivotovsky, and Pierluigi Nicotera. Regulation of Cell Death: The Calcium–Apoptosis Link. Nature Reviews Molecular Cell Biology, 2003.
Pinton, Paolo, et al. Calcium and Apoptosis: ER-mitochondria Ca 2+ Transfer in the Control of Apoptosis. Oncogene, 2008.
Salazar-Cantú, Ayleen, et al. Role of SERCA and the Sarcoplasmic Reticulum Calcium Content on Calcium Waves Propagation in Rat Ventricular Myocytes. Archives of Biochemistry and Biophysics, 2016.
Schwaller, Beat. Cytosolic Ca2+ Buffers are Inherently Ca2+ Signal Modulators. Cold Spring Harbor Perspectives in Biology, 2020. Web.
Spinelli, Amy M., and Mohamed Trebak. Orai Channel-Mediated Ca2+ Signals in Vascular and Airway Smooth Muscle. American Journal of Physiology-Cell Physiology, 2016.
Umemoto, Terumasa, et al. Ca2+–Mitochondria Axis Drives Cell Division in Hematopoietic Stem Cells. Journal of Experimental Medicine, 2018.
Varghese, Elizabeth, et al. Anti-Cancer Agents in Proliferation and Cell Death: The Calcium Connection. International Journal of Molecular Sciences, 2019.